ArticleFrontiers in pharmacology2025

Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles.

Ettore Silvagni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.